Condition: Non Small Cell Lung Cancer · Sponsor: STCube, Inc.
A Multicenter, Phase 2 Clinical Trial Based on an Adaptive Design to Evaluate the Safety and Efficacy of Nelmastobart in Combination with Docetaxel in Patients with Advanced/Metastatic Non-Small Cell Lung Cancer Who Are Resistant or Intolerant to Platinum-based Chemotherapy and/or Immunotherapy
This description comes directly from the study's public registry record.
Heeyeon Jung · 82-2-551-3370 · junghy@stcube.com
Always discuss trial participation with your own doctor first.
| The Catholic University of Korea St. Vincent's Hospital | Gyeonggi-do, South Korea | Recruiting |
| Kangbuk Samsung Hospital | Seoul, South Korea | Recruiting |
| Korea University Anam Hospital | Seoul, South Korea | Recruiting |
| Samsung Medical Center | Seoul, South Korea | Recruiting |
| Seoul National University Bundang Hospital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07306624